Isolated lung perfusion with gemcitabine in a rat: Pharmacokinetics and survival

Journal of Surgical Research

Volumn 109, Issue 2, 2003, Pages 118-122

  Van Putte, Bart P ^a   Hendriks, Jeroen M ^a   Romijn, Sander ^a   Pauwels, Bea ^a   Friedel, Godehard ^c   Guetens, Gunther ^b   De Bruijn, Ernst A ^b   Van Schil, Paul E Y ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c Klinik Schillerhoehe   (Germany)

Author keywords

Gemcitabine; Isolated lung perfusion; Lung metastases; Oncology; Pharmacokinetics; Resection; Survival

Indexed keywords

GEMCITABINE; SODIUM CHLORIDE; STARCH; SULFORHODAMINE B; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE;

ADENOCARCINOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL SURVIVAL; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; ISOLATED LUNG; LUNG PERFUSION; LUNG RESECTION; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; ANIMAL MODEL; CELL CULTURE; COLORECTAL TUMOR; COMPARATIVE STUDY; DRUG EFFECT; EVALUATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG TUMOR; METASTASIS; PATHOLOGY; REGIONAL PERFUSION; SURVIVAL;

ADENOCARCINOMA; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CELL SURVIVAL; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COLORECTAL NEOPLASMS; DEOXYCYTIDINE; INFUSIONS, INTRAVENOUS; LUNG NEOPLASMS; MALE; MODELS, ANIMAL; RATS; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 0037295448     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-4804(02)00063-X     Document Type: Article

References (19)

1. Parker S.L., Tong T., Bolden S., Wingo P.A. Cancer statistics, 1996. CA Cancer J. Clin. 46:1996;5.
2. Pastorino U., Buyse M., Friedel G., Ginsberg R.J., Girard P., Goldstraw P., Johnston M., McCormack P., Pass H., Putnam J.B., Toomes H. Long-term results of lung metastasectomy Prognostic analysis based on 5206 cases . J. Thorac. Cardiovasc. Surg. 113:1997;37.
3. Lehnert T., Knaebel H.P., Duck M., Bulzebruck H., Herfarth C. Sequential hepatic and pulmonary resections for metastatic colorectal cancer. Br. J. Surg. 86:1999;241.
4. Yano T., Fukuyama Y., Yokoyoma H., Tanaka Y., Miyagi J., Kuninaka S., Asoh H., Ichinose Y. Failure in resection of multiple pulmonary metastases from colorectal cancer. J. Am. Coll. Surg. 185:1997;120.
5. Wang H.Y., Port J.L., Hochwald S.N., Burt M.E. Revised technique of isolated lung perfusion in the rat. Ann. Thorac. Surg. 60:1995;211.
6. Ng B., Lenert J.T., Weksler B., Port J.L., Ellis J.L., Burt M.E. Isolated lung perfusion with FUDR is an effective treatment for colorectal adenocarcinoma lung metastases in rats. Ann. Thorac. Surg. 59:1995;205.
7. Hendriks J.M.H., Van Schil P.E.Y., De Boeck G., Lauwers P.R.M., Van Oosterom A.A.T., Van Marck E.A.E., Eyskens E.J.M. Isolated lung perfusion with melphalan and tumor necrosis factor for metastatic pulmonary adenocarcinoma. Ann. Thorac. Surg. 66:1998;1719.
8. Hendriks J.M.H., Van Schil P.E.Y., Van Oosterom A.A.T., Kuppen P.J.K., Van Marck E., Eyskens E. Isolated lung perfusion with melphalan prolongs survival in a rat model of metastatic pulmonary adenocarcinoma. Eur. Surg. Res. 31:1999;267.
9. Tonkinson J.L., Worzalla J.F., Teng C.H., Mendelsohn L.G. Cell cycle modulation by a multitargeted antifolate, LY231514, increases the cytotoxicity and antitumor activity of gemcitabine in HT29 colon carcinoma. Cancer Res. 59:1999;3671.
10. Adjei A.A., Erlichman C., Sloan J.A., Reid J.M., Pitot H.C., Goldberg R.M., Peethambaram P., Atherton P., Hanson L.J., Alberts S.R., Jett J. Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors. J. Clin. Oncol. 18:2000;1748.
11. Skehan P., Storeng R., Scudiero D., Monks A., McMahon, Vistica D., Warren J.T., Bokesch H., Kenney S., Boyd M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82:1990;1107.
12. Papazisis K.T., Geromichalos G.D., Dimitriadis K.A., Kortsaris A.H. Optimization of the sulphorhodamine B colorimetric assay. J. Immunol. Methods. 208:1997;151.
13. Hendriks J.M.H., Van Schil P.E.Y., Eyskens E.J.M. Modified technique of isolated left lung perfusion in the rat. Eur. Surg. Res. 31:1999;93.
14. Van Putte B.P., Hendriks J.M.H., Romijn S., Guetens G., De Boeck G., De Bruijn E.A., Van Schil P.E.Y. Single-pass isolated lung perfusion versus recirculating isolated lung perfusion with melphalan in a rat model. Ann. Thorac. Surg. 74:2002;893.
15. De Boeck G., Van Cauwenberghe K., Eggermont A.M., Van Oosterom A.T., De Bruijn E.A. Determination of melphalan and hydrolysis products in body fluids by GC-MS. High Res. Chromatogr. 12:1997;697.
16. Hendriks J., Romijn S., Van Putte B., Vermorken J., Van Marck E., Eyskens E., Van Schil P. Long-term results of surgical resection of lung metastases. Acta Chir. Belg. 101:2001;267.
17. Weksler B., Schneider A., Ng B., Burt M. Isolated single-lung perfusion in the rat An experimental model . J. Appl. Physiol. 74:1993;2736.
18. Nawata S., Abecasis N., Ross H.M., Abolhoda A., Cheng H., Sachar K.S., Burt M.E. Isolated lung perfusion with melphalan for the treatment of metastatic pulmonary sarcoma. J. Thorac. Cardiovasc. Surg. 12:1996;1542.
19. Weksler B., Ng B., Lenert J.T., Burt M.E. Isolated single-lung perfusion with doxorubicin is pharmacokineticly superior to intravenous injection. Ann. Thorac. Surg. 56:1993;209.